Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
KCNA7	HAK6, Kv1.7	ENSG00000104848	Potassium voltage-gated channel subfamily A member 7	Q96RP8	19	49067418-49072941	FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	9	skeletal muscle: 40.6	Cell type enriched	Detected in some	4	Alveolar cells type 2: 25.9	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HMC-1: 4.0;U-251 MG: 4.0	Not detected	Not detected			Not detected	Not detected																unprognostic (2.00e-1)	unprognostic (2.10e-2)		unprognostic (1.19e-1)	unprognostic (2.72e-1)	unprognostic (1.68e-1)		unprognostic (4.31e-2)	unprognostic (3.17e-2)	unprognostic (6.97e-2)	unprognostic (2.94e-2)	unprognostic (1.26e-1)	unprognostic (2.21e-8)	unprognostic (1.70e-1)	unprognostic (2.62e-1)	unprognostic (5.80e-2)	unprognostic (5.29e-2)	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	40.6	0.2	0	0	0	0	0	0	0	0	0.9	4.6	0.3	0	0	1.1	0.9	3.3	0.8	0.9	0.8	0.2	0.7	0.3	0.4	2	0	0.2	0.7	0.4	0	0.1	0	0.5	0.9	0.4	0.2	0.2	0.7	1.3	0.1	0.2	0	0.4	0.6	0.2	1.5	0.4	0.2	0.6	4	0.1	0.3	0.1	0.1	0.4	0	0.4	0.5	1.1	0.1	0.5	0.3	0.7	0.5	0.3	0.3	0.4	0.2	0.5	0.2	0.5	0.4	0.4	1.5	0.3	0.1	0.6	0.5	1.1	0.7	1.4	0.5	0.9	4	0.7	0.3	0.3	0.6	0.4	0.5	3.3	0.8	0.7	0.8	0.4	0.5	0.5	0.7	0.7	0.2	1.1	0.7	0.8	2.6	0.9	0.7	0.9	0.2	0.2	0	0	0	0	0	0	0	0	0	0	6	25.9	0	1.2	0.3	0.4	3.1	0	1.4	5.7	0	5.9	0	0	0	0.2	0.3	0	0	0.2	0.1	0.4	0.5	3.5	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0.2	2.2	0	0	0	1.6	0	0.1	0.1	0.7	0.3	0.9	0	0	0.3	Alveolar cells type 2
SFTPA1	COLEC4, SFTP1, SP-A, SP-A1	ENSG00000122852	Surfactant protein A1	Q8IWL2	10	79610939-79615455	Disease related genes, Predicted secreted proteins	Gaseous exchange			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	66	lung: 411.8	Cell type enriched	Detected in some	12	Alveolar cells type 2: 12618.9	Cancer enriched	Detected in some	25	lung cancer: 706.4	Not detected	Not detected			Cell type enriched	Detected in single	63	plasmacytoid DC: 6.2	Lineage enriched	Detected in single	63	dendritic cells: 6.2	Cell line enriched	Detected in some	6	RPMI-8226: 30.8									CAB016793, HPA042638, HPA045752, HPA049368	Supported				Secreted in other tissues							CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731						unprognostic (5.83e-4)		unprognostic (1.17e-1)			unprognostic (3.38e-2)	unprognostic (4.24e-1)		unprognostic (3.47e-2)		unprognostic (9.09e-2)		0.1	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	411.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	6.2	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0.1	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	2.8	0.1	0	0	0	0	30.8	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	5.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.2	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	1077.9	12618.9	0	0	0	0	0	0	156.6	337.8	0	0	0	0	0	0	0	0	0	0	0	0	0	418.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
GPR42	FFAR3L, GPR41L, GPR42P	ENSG00000126251	G protein-coupled receptor 42 (gene/pseudogene)	O15529	19	35370929-35372962	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adipose tissue: 2.3;blood: 2.1;intestine: 2.1	Cell type enriched	Detected in single	4	Alveolar cells type 2: 3.4	Not detected	Not detected							Group enriched	Detected in some	5	eosinophil: 1.9;neutrophil: 2.1	Lineage enriched	Detected in single	5	granulocytes: 2.1	Cell line enhanced	Detected in some		HHSteC: 1.0;RPMI-8226: 1.1									HPA044681	Uncertain											HPA044681: AB_2679043											unprognostic (1.73e-3)			unprognostic (1.31e-4)				2.3	0	0	1.5	0.1	0.1	1.2	0	0.2	0	1.7			0	0	0	0	0	0.3	0	0.1	0	0	0.2	0.1	0.1	0.1		0	0.1	1.3	0.1	0.4		0.1	0.3		0	0	0	0	2.1	0.2	0.4	0.8	1.3	0			0.5		0	0.3	0	0	0.1	2.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.9	0	0	0	1.9	0	0.4	0	0	0	0	0.1	0	0	0	2.1	0	0.3	0	0	0											0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0.8	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	Alveolar cells type 2
IQCN	KIAA1683	ENSG00000130518	IQ motif containing N	Q9H0B3	19	18257097-18274509	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	testis: 59.9	Cell type enriched	Detected in some	13	Alveolar cells type 2: 58.5	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enhanced	Detected in many		neutrophil: 5.3	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		A549: 5.9									HPA042409	Enhanced											HPA042409: AB_10794421	unprognostic (1.36e-3)	unprognostic (5.42e-3)	unprognostic (2.21e-1)	unprognostic (1.70e-1)	unprognostic (1.05e-1)	unprognostic (2.15e-4)	unprognostic (9.79e-2)	unprognostic (9.53e-3)	unprognostic (5.44e-2)	unprognostic (1.12e-1)	unprognostic (1.64e-4)	unprognostic (4.17e-2)	unprognostic (2.58e-1)	unprognostic (1.88e-1)	unprognostic (7.68e-2)	unprognostic (1.30e-1)	unprognostic (4.92e-3)	0.8	0.2	0.7	0.7	0.7	2.3	1.2	1.5	0.7	1.7	0.7	0.7	0.7	0	2.7	1.6	0.7	2.4	0.7	0.7	0.7	0.6	1	2.7	1.5	0.7	0.7	0.7	2.7	0.8	0.4	1.6	0.7	0.7	0.8	0.4	0.7	0.7	0.7	1.3	2.2	1	1	0.7	1.4	0.8	59.9	0.7	0.7	2	0.7	0.7	0.7	0.9	2.4	2	5.3	1	1.3	1.2	0.4	0	5.9	0.9	3.6	1.6	2.8	1	0.8	0.7	0	0.4	1.9	2	1.5	0.6	1.8	1	0.1	0	0.6	0	1.6	0.4	2.2	2.2	1.2	0.2	0.4	0.7	1.5	0.5	0.5	1.1	3.3	0.7	0.3	0.3	1.7	0	2.3	0.7	1	0.7	1.5	0	0.5	0	0.6	0.9	1.4	2.7	0.6	0.5	0.9	1.3	2	2	0.7	0	0.2	0.7	2.1	0	0.8	0.5	0.5	1.2	0.1	0	1.4	1	0.8	1.1	0.4	0.5	1	1	0.4	0.3	2.4	1.2	0.9	5.3	1.3	0.4	2	0.7	0.4	0.7	0.7	1.5	0.7	0.7	0.6	0.7	0.7	0.7	0.7	3	58.5	0	0	0	0	0	0	4	2.3	1.8	0	1.2	0	1.6	0	0	0	0	0.8	0.3	0	0	4.7	0	2.4	0	0	0	0	0	0	0	0	1.8	0	0	0.8	0	0	0.2	0	0	0	0	0	0	1.5	0	0	0	Alveolar cells type 2
NAPSA	KAP, Kdap, NAP1, NAPA	ENSG00000131400	Napsin A aspartic peptidase	O96009	19	50358477-50365830	Enzymes, Plasma proteins, Predicted secreted proteins		Aspartyl protease, Hydrolase, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	kidney: 47.5;lung: 153.3	Cell type enriched	Detected in many	5	Alveolar cells type 2: 2552.8	Cancer enriched	Detected in many	18	lung cancer: 249.9	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 10.5	Group enriched	Detected in many	9	B-cells: 5.1;dendritic cells: 10.5	Cell line enriched	Detected in some	24	U-698: 29.8	Low region specificity	Detected in single			Low region specificity	Detected in all			CAB009591, HPA045280, HPA047236, HPA047744	Enhanced				Secreted in other tissues				380000			CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143	unprognostic (5.36e-2)	unprognostic (4.77e-2)	unprognostic (1.64e-3)	unprognostic (1.78e-1)	unprognostic (1.93e-1)	unprognostic (4.65e-2)	unprognostic (1.02e-1)	unprognostic (8.30e-3)	unprognostic (2.29e-1)	unprognostic (2.23e-2)	unprognostic (1.76e-3)	unprognostic (7.67e-3)	prognostic favorable (1.21e-4)	unprognostic (4.08e-4)	unprognostic (3.29e-1)	unprognostic (9.83e-3)	unprognostic (7.26e-5)	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	5	0.1	0.1	0.1	0.1	0.1	0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.5	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.2	0.4	0	0.2	0.2	0.2	0.1	0.1	0	0	0.1	0.1	0.4	0.2	0.2	0.1	0	0.5	0.1	0	0	0.2	0.6	0	0	0	0.2	0	0.2	0.3	1.2	0.1	0	0.1	0	0	0.3	0.1	0	0.6	0.1	0.3	0.2	0.3	0.3	0.6	0	0.1	0.9	0	0	0.1	0.3	0	0.1	0.1	0.1	0.3	0.1	0	0.1	0.8	0	0.2	0.4	29.8	0	0.1	0	0	0.4	0	0.1	0.9	0	5.1	0.2	0.4	3	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0	1.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	485.3	2552.8	8	0.4	0.1	1.3	0.4	0	29.4	84.2	43.6	3.9	0.4	8.3	0.4	34.9	0.1	0.9	0	0.7	0.2	0.2	0.6	64	0	0.3	0	0	0	0.3	4.5	0.9	4	0	0	0.9	1.3	0.1	2.8	0.4	230.9	0.7	0	0.3	0.5	0.7	0.5	0.1	0	0.8	0	Alveolar cells type 2
CHIA	AMCase, CHIT2, TSA1902	ENSG00000134216	Chitinase, acidic	Q9BZP6	1	111290862-111320566	Enzymes, Predicted intracellular proteins	Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation	Glycosidase, Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	stomach 1: 66.6	Cell type enriched	Detected in some	8	Alveolar cells type 2: 22.2	Cancer enhanced	Detected in some		lung cancer: 1.8;stomach cancer: 2.0	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.6	Low lineage specificity	Detected in single			Group enriched	Detected in some	4	ASC diff: 6.0;HAP1: 3.1					Low region specificity	Detected in single			HPA059193	Approved				Intracellular and membrane							HPA059193: AB_2683942				unprognostic (8.00e-2)	unprognostic (7.08e-2)			unprognostic (2.02e-2)					unprognostic (4.99e-2)	unprognostic (7.93e-2)	unprognostic (1.46e-1)	unprognostic (1.06e-2)		0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0	0.5	1	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0	0.1	0.6	0.6	0.3	0	0	0	0	6	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	3.1	0	0	1	0	0	0	0	0.4	0	0.6	0.5	0	0	0.2	0.5	0.1	0.2	0	0	0.3	0	0.2	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0.6	0	0.1	0.5	0	0	0	0	0.2	0	0	0.1	0	0	0	0.1	0	0.3	0.1	0.1	0.7	0.2	0.2	0	1.6	0.6	0	0	0.6	0	0.7	0	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	22.2	0	0	0	0	0.2	0	0	1.2	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
SLC6A3	DAT, DAT1	ENSG00000142319	Solute carrier family 6 member 3	Q01959	5	1392790-1445430	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Neurotransmitter transport, Symport, Transport		Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	brain: 48.4	Cell type enriched	Detected in single	5	Alveolar cells type 2: 2.9	Cancer enriched	Detected in some	18	renal cancer: 25.7	Region enriched	Detected in some	47	midbrain: 48.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8	Group enriched	Detected in some	8	midbrain: 96.4;thalamus: 31.8	Region enriched	Detected in single	138	midbrain: 362.2	HPA012763, HPA013602, CAB016249, CAB078172	Enhanced	Supported	Approved	Vesicles						Vesicles		CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484	unprognostic (2.25e-4)	unprognostic (2.22e-1)	unprognostic (8.45e-2)	unprognostic (5.24e-2)	unprognostic (7.75e-2)	unprognostic (1.41e-2)	unprognostic (4.64e-5)	unprognostic (9.31e-2)	unprognostic (7.89e-2)	unprognostic (4.81e-2)	unprognostic (1.30e-1)	unprognostic (2.12e-2)	prognostic unfavorable (3.40e-7)	unprognostic (6.98e-2)	unprognostic (1.64e-1)	unprognostic (2.22e-2)	unprognostic (4.74e-2)	0.2	0.1	0	0	0.7	0	0.1	0	0.3	0.7	0	0	0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0	0.6	0.3	0	3.4	0	48.4	0	1.5	0	0	0	0.1	1	0.7	0	1.7	0	0.1	0	0	0	1.3	0	0.1	0	0.8	0	2.4	2.2	0	0.3	0.2	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	1.2	0	0	0	0	2.1	0	0.1	3.8	0	0	0.1	0	0.4	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.2	0.1	0.4	0	0	0	0	0	0	0	0.7	0	0.3	0	0.6	48.4	0	1	0	0	2.9	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	Alveolar cells type 2
ACOXL	FLJ11042	ENSG00000153093	Acyl-CoA oxidase like	Q9NUZ1	2	110732573-111118222	Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 29.7;lung: 20.8;placenta: 23.8	Cell type enriched	Detected in some	5	Alveolar cells type 2: 27.4	Group enriched	Detected in some	6	lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 4.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	4	A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4	Not detected	Not detected			Low region specificity	Detected in some			HPA035392, HPA035393			Supported	Nucleoli,Cytosol						Cytosol	Nucleoli	HPA035392: AB_2674604, HPA035393: AB_2674605	unprognostic (1.62e-1)	unprognostic (7.30e-2)	unprognostic (6.77e-4)	unprognostic (2.93e-7)	unprognostic (1.32e-2)	unprognostic (7.84e-5)	unprognostic (1.28e-1)	unprognostic (1.53e-2)	unprognostic (1.29e-1)	unprognostic (7.31e-2)	unprognostic (7.24e-2)	unprognostic (3.24e-1)	unprognostic (1.72e-1)	unprognostic (2.11e-1)	unprognostic (2.73e-1)	unprognostic (1.72e-1)	prognostic favorable (6.48e-4)	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1	0.6	4.1	1.1	0.7	0.6	0.3	9.1	0	0.2	0.3	0.1	0	0.4	0.1	0	0	0	0.6	0.6	0.2	0.2	0.1	0.2	1	0	0	0	0.2	3.2	0.2	0.4	0.2	0	0.1	0.2	0.1	1	0	0.1	0.3	0	0.4	1.4	1.4	0.1	3.3	0.7	0.4	3.1	0.1	0.4	0.1	0.2	16.5	0	21.3	2	0.4	0.1	0.4	0.1	0.7	0.2	1	0.3	0.2	0.4	0.2	0.1	14.4	3.7	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0	27.4	0	0.2	0.2	0.6	0.4	0	0	1.2	0	0	0	0	0.1	4.3	0	0	0	0	0	0.4	0.9	0	0	0.1	0	1.2	0	0	5.9	0	0	0	0	0	0	0.1	0.2	0	0	0.4	0	0.3	0.9	2.2	0.3	0	0	0	0.7	Alveolar cells type 2
OR3A3	OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P	ENSG00000159961	Olfactory receptor family 3 subfamily A member 3	P47888	17	3411370-3424070	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	blood: 10.6;bone marrow: 2.6	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Not detected	Not detected							Cell type enriched	Detected in single	17	plasmacytoid DC: 10.6	Lineage enriched	Detected in single	17	dendritic cells: 10.6	Cell line enriched	Detected in single	5	HDLM-2: 4.4																																				unprognostic (2.01e-1)			0.1	0	0.6	0.2	0.9	2.6	0.1	1.2	0.4	0.2	0.2			0.5	0.4	0.1	0	0.2	0.5	0.2	0.6	0.5	0.2	0.2	0.1	0.8	1.1		0.1	0	0	0.3	0.4		0.1	0		0.1	0.1	0.5	1	0	0	0.5	0.4	0.4	1.1			0.2		0.4	0.3	0.2	0.3	10.6	0.6	0.2	0.2	0.2	0	0.2	0.1	0.3	0.2	0	0.1	0.4	0	0	0	0.1	0.5	0.1	0.3	0.1	0	0.1	0.2	0.1	0	0	4.4	0.5	0.4	0.6	0.2	0	0.3	0.2	0	0	0	0.4	0.3	0	0.2	0.4	0.4	0	0.3	0.4	0.4	0	0	0.1	0	0	0	0	0.1	0.2	0	0.1	0.2	0.2	0.3	0.1	0.2	0.9	0.3	0.2	0.1	0	0.3	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0	0.3	0.2	0.2	0.6	0.2	0.1	10.6	0.1	0											0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
ABCA3	ABC-C, ABC3, EST111653, LBM180	ENSG00000167972	ATP binding cassette subfamily A member 3	Q99758	16	2275881-2340746	Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.8;lung: 75.8	Cell type enriched	Detected in many	6	Alveolar cells type 2: 382.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA007884: AB_1078077	unprognostic (2.64e-1)	unprognostic (2.19e-2)	unprognostic (6.09e-3)	unprognostic (2.61e-3)	unprognostic (2.20e-1)	unprognostic (1.35e-1)	unprognostic (2.90e-2)	unprognostic (1.86e-1)	unprognostic (6.58e-3)	unprognostic (3.67e-2)	unprognostic (1.71e-3)	unprognostic (2.22e-2)	unprognostic (5.33e-2)	unprognostic (3.32e-2)	unprognostic (7.85e-2)	unprognostic (2.91e-1)	unprognostic (1.30e-1)	6.3	6.2	12.9	3.4	15.3	1.6	7	21.9	30.8	3	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6	4.7	18.3	5.3	2.1	4.9	8.5	5	5	4.2	2.5	5	11.3	3.7	3	7.2	6.1	5.6	16.2	0.5	6.4	3	1.3	0.2	0.5	0	0.6	2	1.5	0.4	0.3	9.7	1.8	15.1	0.4	0	0.1	2.6	0.6	1	1.1	1.3	1.5	0.1	3.8	1.2	0.9	0.2	8.7	0.1	0.3	15.2	5.8	1	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	6.2	14.7	0.1	10.4	0	0	12.9	0	1	2	2.3	4.7	2.4	0.3	1.7	8.7	0.3	21.2	15.3	1.8	10.7	0.2	0.8	34.9	0.9	4.2	0.1	0.5	4.1	4.3	2.8	1.2	0	2.1	5.2	0.1	0	0.1	0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0	2	0.6	0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1	65.5	382	0	0.4	0.6	16.5	5.1	2.5	4	17	17.4	11.8	0	0	4.6	7.7	4.2	0.2	0	3.3	0	1.4	1.9	27.8	0.9	0.9	17.5	5.2	2.5	2.7	2.7	1.7	1.6	1.7	2.8	0.7	6.9	2.4	0	3.2	1.5	9.5	6.5	3.1	1.9	14	1.4	0	2.5	0.6	0.1	Alveolar cells type 2
SFTPC	BRICD6, PSP-C, SFTP2, SMDP2, SP-C	ENSG00000168484	Surfactant protein C	P11686	8	22156913-22164479	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Gaseous exchange		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	718	lung: 664.5	Cell type enriched	Detected in some	10	Alveolar cells type 2: 80228.9	Cancer enriched	Detected in some	218	lung cancer: 226.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 8.4;NB-4: 10.7;SCLC-21H: 4.6;U-2197: 22.7	Low region specificity	Detected in many			Not detected	Not detected			HPA010928	Enhanced				Secreted in other tissues							HPA010928: AB_1857425		unprognostic (1.84e-1)			unprognostic (1.96e-1)	unprognostic (1.44e-1)		unprognostic (1.13e-1)	unprognostic (2.97e-1)		unprognostic (4.97e-2)	unprognostic (1.08e-1)		unprognostic (1.50e-1)		unprognostic (1.32e-2)		0.1	0.8	0.2	0.3	0.5	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0.3	0.1	0.1	0.1	664.5	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.9	0.1	0	0.1	0.2	0.3	0.1	0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	8.4	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	10.7	0.3	0	0	0.4	0	0	0	0	4.6	0.3	0	0	1.3	0	0	0	0	0	0.1	22.7	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.5	0.1	0.2	0.3	0.1	0.4	0.1	0.9	0.1	7929.7	80228.9	0	0	1.5	0	0.3	0	623.7	2602.4	0	0	0	0	0	6.2	0	0	0	0	0	0	0	909.1	0	0	0	0	0	0	20.2	0	0	21.9	0	0	0	0	0	0	0	0	6.5	0.1	0	0.1	0.5	0	0	0	0	Alveolar cells type 2
PLA2G4F	PLA2G4F/Z	ENSG00000168907	Phospholipase A2 group IVF	Q68DD2	15	42139034-42156636	Enzymes, Predicted intracellular proteins, RAS pathway related proteins	Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lung: 30.4;skin 1: 48.1	Cell type enriched	Detected in many	5	Alveolar cells type 2: 54.9	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	OE19: 14.1;RT4: 10.6	Not detected	Not detected			Low region specificity	Detected in some			HPA042713, HPA056752	Enhanced		Approved	Nucleoplasm,Vesicles						Vesicles	Nucleoplasm	HPA042713: AB_10793982, HPA056752: AB_2683226	unprognostic (1.99e-1)	unprognostic (6.21e-3)	unprognostic (1.59e-1)	prognostic unfavorable (2.00e-4)		unprognostic (1.06e-2)	unprognostic (2.32e-3)	unprognostic (1.48e-2)	unprognostic (5.85e-2)	unprognostic (2.25e-1)	unprognostic (4.79e-2)	unprognostic (6.65e-2)	unprognostic (1.21e-2)	unprognostic (9.32e-2)	unprognostic (1.11e-1)	unprognostic (4.55e-2)	unprognostic (1.63e-1)	0.1	0.1	0	2.5	0.3	0.3	1.8	0	0.1	4.5	11	0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1	0	0	10.8	0.2	30.4	0.1	0	0	0.1	0.1	0.7	4.1	0.3	0	3.3	2.5	0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0	0.3	0.2	0.2	0	0.1	0	0	0	0.2	0	0	0.1	0	1.4	0.4	0.1	0.1	0	0	0.1	0	0	0	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0	2.5	0	0	0	0	0.1	0	0.1	0	1	0	0.1	0	14.1	0.1	0	0	0.1	0	10.6	0.6	0.1	0	1.1	0	0.1	1.1	0	0.1	0.1	0	0.1	0	0.1	0.2	0	0	0.1	0	0.1	0	0	0	0.1	0.3	0.2	0	0	0	0.6	0	0	0.2	0	0	0.3	0.2	0.2	0	0.3	0	0	0	0	0	0	0	0	8.9	54.9	0	3.3	4.8	0	3.2	0	0	0	5.2	0	1.5	3.3	0.2	0	0	12	0	1.2	0.7	0.2	2.7	2.3	0	0.1	0	0	0	0	0	0	0.1	1.7	0	4	0	0.2	4.8	0	0	0	0	0	0	0	12	1	0	4.3	1.6	Alveolar cells type 2
CCR8	CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1	ENSG00000179934	C-C motif chemokine receptor 8	P51685	3	39329706-39333511	CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	7	blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in some	5	T-reg: 19.8	Lineage enriched	Detected in single	30	T-cells: 19.8	Cell line enriched	Detected in some	22	HDLM-2: 50.0	Not detected	Not detected			Low region specificity	Detected in all			HPA042383	Enhanced											HPA042383: AB_2732497	unprognostic (2.16e-1)	unprognostic (2.12e-2)	unprognostic (2.91e-2)	unprognostic (1.04e-1)	unprognostic (2.38e-2)	unprognostic (7.63e-4)	unprognostic (3.31e-1)	unprognostic (1.27e-1)	unprognostic (2.30e-3)	unprognostic (3.37e-2)	unprognostic (7.40e-2)	unprognostic (2.99e-1)	unprognostic (4.65e-8)	unprognostic (7.96e-2)	unprognostic (2.24e-2)	unprognostic (2.56e-1)	unprognostic (4.14e-1)	0.3	0.2	0.2	3.1	0.2	0	0.3	0.2	0.2	0.3	0.5	0.1	0.1	0	0.3	0.1	0.8	0.1	2.1	0.2	0.2	0.2	0.5	0.3	1.4	2.8	0.1	0.1	0.2	0.3	0	0.2	0.1	0.1	0.4	1.3	0.1	0.5	0.1	0.2	1	1.2	0.1	0.4	1.7	0.8	0.3	0.1	19.3	0.4	1.2	3.5	5.3	0.3	0	0	0	0	0.6	19.8	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.1	1.3	2.2	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	1.8	0	0	0.2	0	0	0.6	0	0	19.8	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
AGTR2	AT2, MRX88	ENSG00000180772	Angiotensin II receptor type 2	P50052	X	116170722-116174972	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6	Cell type enriched	Detected in some	15	Alveolar cells type 2: 17.8	Group enriched	Detected in some	12	endometrial cancer: 3.0;lung cancer: 1.9	Region enriched	Detected in single	10	cerebellum: 1.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	HSkMC: 1.4	Low region specificity	Detected in many			Region enriched	Detected in single	9	cerebellum: 3.8																	unprognostic (2.13e-1)				unprognostic (1.71e-1)			unprognostic (3.22e-2)				unprognostic (4.37e-2)			0.3	1.6	0.1	0.8	0.1	0	0.1	1	0.1	5.3	0.4	0.1	0.1	0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	17.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
SFTPA2	COLEC5, SP-A2	ENSG00000185303	Surfactant protein A2	Q8IWL1	10	79555852-79560402	Disease related genes, Predicted secreted proteins	Gaseous exchange		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	225	lung: 501.0	Cell type enriched	Detected in some	10	Alveolar cells type 2: 14379.1	Cancer enriched	Detected in many	21	lung cancer: 863.5	Not detected	Not detected			Cell type enriched	Detected in single	11	plasmacytoid DC: 2.2	Lineage enriched	Detected in single	11	dendritic cells: 2.2	Group enriched	Detected in some	21	BEWO: 6.5;NB-4: 6.8;RPMI-8226: 21.7;U-2197: 13.1									CAB002439, HPA042638, HPA045752, HPA049368	Enhanced				Secreted in other tissues							CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731	unprognostic (2.51e-1)	unprognostic (4.87e-2)	unprognostic (4.99e-2)	unprognostic (4.38e-2)	unprognostic (4.29e-2)	unprognostic (1.05e-1)		unprognostic (5.78e-2)	unprognostic (5.08e-1)	unprognostic (4.94e-2)	unprognostic (1.68e-3)	unprognostic (3.10e-1)	unprognostic (3.56e-2)	unprognostic (1.20e-1)		unprognostic (1.33e-1)	unprognostic (4.69e-3)	0.1	0.4	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	501	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	1.2	0	0.1	0.4	0.3	0.1	0	0.2	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0	2.2	0	0	0	0.2	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0.5	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	6.8	0.4	0	0	0.2	0	21.7	0	0.3	0.2	0.3	0	0.2	0	0	0.5	0	0	0	0.2	13.1	0.1	0.5	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	1479.9	14379.1	0	0	0	0	0	0	248.9	606.2	0	0	0	0	0.1	0.1	0	0	0	2.7	0	0	1	397.6	0	0	0	1.7	0	0	0	0	0	0	0	0.4	0	1.7	2.5	0	0	0	0	0	0	0	0	0	0	2.3	0	Alveolar cells type 2
LRRK2	DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2	ENSG00000188906	Leucine rich repeat kinase 2	Q5S007	12	40196744-40369285	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Autophagy, Differentiation	GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase	Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	blood: 40.4;lung: 50.4	Cell type enriched	Detected in many	5	Alveolar cells type 2: 391.0	Group enriched	Detected in many	7	lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7	Low region specificity	Detected in all			Cell type enriched	Detected in many	7	neutrophil: 40.4	Lineage enriched	Detected in many	7	granulocytes: 40.4	Cell line enhanced	Detected in some		A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA014293, CAB037160	Approved		Supported	Vesicles						Vesicles		CAB037160: AB_1840989, HPA014293: AB_1853353	unprognostic (2.67e-1)	unprognostic (1.75e-1)	unprognostic (6.45e-3)	unprognostic (1.06e-1)	unprognostic (3.00e-2)	unprognostic (6.10e-3)	unprognostic (2.71e-1)	unprognostic (3.14e-1)	unprognostic (2.25e-1)	unprognostic (9.07e-2)	unprognostic (2.76e-1)	unprognostic (1.23e-1)	prognostic favorable (3.02e-6)	unprognostic (2.55e-2)	unprognostic (3.43e-2)	unprognostic (2.01e-3)	unprognostic (5.21e-3)	3.7	3.4	2.3	7	3.9	8.6	3	1.7	5	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1	1.9	3.6	1.6	3.3	4.2	2	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0	0	0.8	0	9.9	0.1	0	3.9	10.2	0.1	2.1	5.7	0.4	0.3	0	0	0	0	1.9	0.3	0	0.3	0	0.4	0	0.8	0.3	0.2	0	0.7	0.5	0.1	2.5	0.7	0	0.2	3.8	0.6	0	0	0	0.7	0	0	1.2	0.2	0	0.1	0	0	0	10.9	0	0.1	0.6	0	0.2	2.8	0.3	2.8	2.2	1.4	1.2	1.1	1.2	0.7	0	0	0	2.4	0	0.5	0	5.8	1.2	0	3.1	0	0.9	0	0	1.5	0.9	0	0	40.4	0	3	0.2	0	0.8	2.3	3.9	1.7	5	1.8	1.4	2.2	3.6	1.9	2.4	29.8	391	17.5	1.5	2.2	7.5	6.9	5.1	5.3	30.7	26.2	0	0	1.7	0.8	0.4	4.5	0	0	2.3	0.1	9.4	0.6	12.8	7.8	4.6	44.5	0	9.2	74.8	0	17.5	19.9	11.8	10.8	0	11	1.1	0	11.3	15.2	0.9	0	3.9	0.2	0.4	2.8	0.3	0.8	0	0.5	Alveolar cells type 2
OR3A2	OLFRA04, OR17-228, OR228	ENSG00000221882	Olfactory receptor family 3 subfamily A member 2	P47893	17	3276942-3386317	G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9	Cell type enriched	Detected in some	4	Alveolar cells type 2: 4.6	Cancer enhanced	Detected in single		testis cancer: 0.5	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	6	HDLM-2: 13.1;JURKAT: 14.2																						unprognostic (7.58e-2)				unprognostic (5.10e-2)						unprognostic (6.89e-2)		unprognostic (1.12e-1)		unprognostic (1.32e-1)			0.5	0.5	2.2	0.5	8.6	0.5	0.6	0.4	2.8	0.6	0.4	1.2	0	0.4	0.5	1.5	0.4	0.3	0.2	0.4	2.5	1.2	0.5	0.3	0.8	6.5	1.4	0.6	1	0.4	0.2	5.5	1	2.7	0.7	0.4	1.3	0.3	0.5	0.8	0.6	0.5	0.4	1.9	0.9	0.4	10.9	2.1	2.3	0.3	0	0.7	0.6	0.4	3	3.4	3.6	0.6	0.7	1.8	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.1	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	3.6	0.6	0.7	0.9	0.3	1.6	3	1.2	0.3	0.8	0.8	1.2	1.8	1.6	0.7	0.4	3.4	0.5	0.8	2.2	8.6	0.4	2.8	2.5	1.2	1.4	0.6	2.7	2.1	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
AC073610.2		ENSG00000255863			12	48921963-48939663	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 1.0;skeletal muscle: 1.5	Cell type enriched	Detected in single	14	Alveolar cells type 2: 1.4	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BJ hTERT+: 2.5;MOLT-4: 1.8;NB-4: 1.1																																							0	0	0	0	0.6	0	0	0	0.1	0	0			0	0	0	0	0	0	0	0.4	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	1.5	0	0	0	0	0	0	0			0.8		0	0	0	0	0.4	0.7	0.8	0.3	1	0.8	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0.8	0	0	0	0.3	0.4	0	0.6	0.5	0.7	0.3	0.7	0	1	0.8											0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
TGIF2-C20orf24		ENSG00000259399	TGIF2-C20orf24 readthrough		20	36574553-36612384	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		pancreas: 22.1	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		AF22: 20.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (7.38e-2)	unprognostic (1.79e-1)	unprognostic (3.92e-2)	unprognostic (5.58e-2)	unprognostic (2.62e-2)	unprognostic (1.94e-1)	unprognostic (7.39e-2)	unprognostic (2.22e-2)	unprognostic (6.57e-3)	unprognostic (3.97e-2)	unprognostic (2.86e-3)	unprognostic (1.72e-1)	unprognostic (1.46e-2)	unprognostic (2.69e-1)	unprognostic (2.93e-1)	unprognostic (3.70e-2)	unprognostic (1.07e-1)	2.1	1.4	1.9	8.5	1.9	4.9	2.3	0.9	3.1	3.1	2.1	1.7	0.6	2.1	4.1	2.6	1.4	4.2	1.7	2.2	1.4	1.1	2	5.3	2.2	1.8	2.5	1.7	3.8	22.1	3.1	1.3	2.7	1.9	1.9	1.5	2	3.2	2.2	2.7	1.5	1.6	4.7	1.6	3	1.4	6.1	1.3	4.1	4	1.4	5.7	1.3	2.8	3.4	3.6	2.8	2.2	1.9	3.3	0.9	3.7	1.6	20.9	10.5	3.1	1.6	1.5	0.7	4.8	7.3	5.6	8.9	7.8	1.7	2.1	4.3	3.1	1.6	17.7	2.6	11.1	4.8	2.1	4.6	5.4	10.1	1.5	5.4	1.1	1.2	2.9	3.9	7.3	9.3	4.9	9.8	1.3	10.7	1.9	9.4	12.4	2.9	4.4	4.1	0.4	9.3	2.1	7.6	2.9	4.5	2.6	7	1.2	9.3	5.3	3.7	8.3	14.9	1.3	2.7	0.9	0.2	2.8	2.4	1.2	6.9	0.2	6.2	4.4	0	1.9	0	2.6	2.2	2.4	3.4	0.6	0.5	3.6	3.4	3.2	3.3	2.8	1.9	0.4	2.6	0.5	0.9	1.9	1.9	0.9	3.1	1.4	1.1	2.5	1.7	1.9	1.3	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
SLC22A31		ENSG00000259803	Solute carrier family 22 member 31		16	89195761-89201664	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in some	21	brain: 39.3;lung: 50.7;pancreas: 69.7	Cell type enriched	Detected in some	6	Alveolar cells type 2: 129.3	Group enriched	Detected in many	9	liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4	Region enriched	Detected in some	23	cerebellum: 39.3	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2																						unprognostic (2.71e-3)	unprognostic (2.53e-1)	unprognostic (5.02e-3)	unprognostic (6.82e-2)	unprognostic (8.20e-2)	unprognostic (1.95e-1)	unprognostic (3.00e-2)	unprognostic (1.93e-2)	unprognostic (2.12e-1)	unprognostic (2.67e-1)	unprognostic (8.98e-2)	unprognostic (1.09e-1)	unprognostic (8.26e-4)	unprognostic (2.74e-1)	unprognostic (2.05e-1)	unprognostic (2.72e-3)	unprognostic (1.89e-1)	0.1	0.3	0	0.3	0.4	1.1	0.1	39.3	0.1	0.3	0.5	0	0	0.6	0.2	0.5	0.1	0.2	0.2	0.1	0.1	0	0.1	0.3	50.7	2.5	0	0	0.7	69.7	0.1	0	0.1	1.7	0.2	0.1	0.4	0.7	0.2	0.1	0.3	0.3	0.1	0.3	1	0.5	1.1	0	0	0.3	0	0.1	0.2	0	0.5	0	0	0.1	0	0.6	0.7	0	0	0	1.1	0	0	23.7	0.1	0	0	0	0.8	0	0	2.7	0	0	0	0	0	0	0	0.6	0	0	19	2.5	0	0.2	0	0	0	0	0	0	0.3	0.3	0	0	0.3	0	9.7	0.6	0.2	2.4	0	2.6	11.4	0	0	1	0.7	0	0	0	0.1	0.2	6.2	0	0	0	0	0	0	0.9	0	0	0.1	0.1	0	0.1	0	0	0	0	0.5	0	0	0	0	0.6	0	0	0	0	0	0	0.7	0	0.4	39.3	0.1	0.1	0	0	0	1.7	0	6	129.3	0	0	0	0	0.4	0	4	14.8	0	0	0	0	0.1	20.8	0	0	0	4.2	0.1	0	0.2	8.1	0.2	0.6	0	0	0.6	0.3	23.1	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0.7	2.8	0.1	0	0	0	0	Alveolar cells type 2
AC026464.4		ENSG00000260914			16	69299682-69322700	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		blood: 28.3	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Not detected	Not detected							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA060092			Approved	Midbody						Midbody		HPA060092: AB_2684203	unprognostic (2.95e-1)	unprognostic (4.21e-1)			unprognostic (7.34e-2)	unprognostic (8.50e-2)		unprognostic (1.02e-1)	unprognostic (2.74e-1)		unprognostic (3.50e-1)	unprognostic (4.08e-2)	unprognostic (6.51e-4)	unprognostic (1.69e-1)		unprognostic (2.76e-1)	unprognostic (5.11e-2)	5.6	3.4	1	2.7	2.2	2.3	4.8	15.1	6.8	5.5	4.5			3.1	9.1	0.6	5	7.5	2	5	1	1.3	3.3	1.4	7.3	2.4	1		6.4	5.7	7.1	3.9	3		3	2.7		3.7	3	19.4	6.4	4.6	3.5	1.2	4.4	3.1	1.3			5.3		3	4.5	5.1	17.5	19.5	24.9	19.1	15.9	28.3	21.1	22.5	20	23.6	22.2	18.2	19.3	13.3	28.6	19.4	30.6	20.2	25.4	12.5	21.5	30	22.9	15.6	17.6	22.4	19.5	19.6	13.2	10.7	17	11	12.6	23	21.3	18.1	16.3	26.9	25.3	28	17.4	25.2	18.6	21.5	10.7	24.8	29.5	21.2	10.4	19.1	14.8	9.7	32.6	13.5	28.6	14.3	14.6	24.6	13.7	38.4	12.8	16.4	15.1	18.1	15.1	26.4	28.6	20.5	24.5	21.5	37.1	26.6	50.6	28.9	8	34	11.1	17.7	24.9	23.6	14.1	22	17.5	21.2	28.3	19.5	15.7	21.8	21.3	12.4	15.9	19.1	13.4	19.9	21.1											0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
AC004233.2		ENSG00000270168			16	2988256-3002016	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	8	skin 1: 8.9	Cell type enriched	Detected in single	30	Alveolar cells type 2: 5.0	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 3.4;HaCaT: 7.3;hTCEpi: 5.5;MCF7: 3.8;OE19: 6.0;SCLC-21H: 5.6																						unprognostic (7.38e-2)	unprognostic (2.28e-1)	unprognostic (1.04e-1)	unprognostic (6.21e-2)	unprognostic (7.98e-3)	unprognostic (1.50e-1)	unprognostic (2.72e-1)	unprognostic (9.48e-2)	unprognostic (2.06e-2)	unprognostic (1.42e-1)	unprognostic (2.30e-1)	unprognostic (3.61e-1)		unprognostic (1.97e-3)	unprognostic (1.28e-1)	unprognostic (6.73e-2)	unprognostic (4.21e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0	0.1	0.1	0.1		0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0	0.1	0.2	0.1	0.6	0.1	0.1	1.1	0.1	0.1	8.9	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.8	0	0	0	0	2.9	0	0	0.8	0	0	0.6	0.4	0.1	0.1	0.5	0.2	3.4	0	0.2	0	0.1	7.3	0	0.2	0.1	0.7	0	0	0.1	0.2	0	0.1	0.4	0.1	5.5	0.2	0	0.1	0	0	0.6	0.3	0	3.8	0	0.4	0	6	0	0	1	0.1	0	0.2	5.6	0.2	0.5	2.3	0.1	0.1	2.9	0.1	0	0	0.2	0.2	0.4	0.2	0	0	0	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0											0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
MUSTN1	Mustang	ENSG00000272573	Musculoskeletal, embryonic nuclear protein 1	Q8IVN3	3	52833114-52835219	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	skeletal muscle: 252.5	Cell type enriched	Detected in single	7	Alveolar cells type 2: 2.2	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 2.1	Lineage enhanced	Detected in single		granulocytes: 2.1	Cell line enhanced	Detected in some		Hep G2: 9.5;HSkMC: 6.0;RH-30: 8.5																						unprognostic (2.79e-2)	unprognostic (3.73e-2)			unprognostic (4.11e-1)	unprognostic (2.60e-2)	unprognostic (2.34e-2)	unprognostic (6.21e-3)	unprognostic (2.78e-1)	unprognostic (1.13e-2)	unprognostic (1.66e-2)	unprognostic (1.04e-1)	unprognostic (1.65e-3)	unprognostic (6.00e-2)	unprognostic (1.79e-1)	unprognostic (8.11e-2)	unprognostic (1.88e-2)	12.1	1.8	2.5	1.8	5.2	1.3	6.1	1.5	5.7	16	4.6	2.6	2.4	1.7	11.1	18.9	7.9	6.4	10.6	15.5	2.6	2.2	1.8	0.8	3.2	1.4	4.3	3.9	5.1	1.6	0.8	1.1	1.3	5.2	11.6	3.4	3.8	5.9	8.9	252.5	2.7	2.6	6.1	2.2	0.9	2.3	6.4	0.2	0	5.4	26.9	3.6	8.1	7.9	0	0	2.1	0.6	0	0.3	0.2	0.1	0.2	3	0	0.8	2.1	3.5	0.2	0.9	0.4	0.3	0.4	0.5	0	0	1.4	0.1	1.3	0.7	0.6	0.5	0.1	0.9	0	1.6	9.5	1.4	1.9	0.6	6	1	0.9	0	1.4	1.2	0.4	0.2	0	0.1	0.6	0.7	2.8	0.4	0.4	2.2	1	8.5	0	0.6	0	0.3	0.3	0.6	0.7	1.5	3.2	0	0.7	0	0.4	0.7	1.2	0.6	0	0.1	0	0.3	2.4	0.3	0	0.4	0	0.3	0	0.2	0	0.3	0	0	0	0	0	2.1	0	0.6	0	0	0.2	2.5	5.2	1.5	5.7	2.6	2.2	4.3	3.9	5.2	0.2	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	Alveolar cells type 2
AC092718.8		ENSG00000284512			16	81022316-81096284	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		testis: 20.6	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA041368	Uncertain		Approved	Vesicles						Vesicles		HPA041368: AB_10804001																		1.4	1.9	3.2	2.1	4.7	4	1.7	1.8	6.9	1.4	1.3	4.4	4	1.4	2	4.2	1.3	1.7	1.6	2.4	3.7		2.5	4.2	1.4	1.9	5.1	4.7	2.2	2.5	3.6	1.4	1.7	5.7	4	1.3	2.6	2.3	1.7	3.2	1.9	1.6	1.3	3.9	1.5	1.7	20.6	5.4	1.2	4.5	0.9	1.2	1.7	0	1.9	2.8	2.3	1	1.7	2.1	0.9	1.3	0.7	1.9	1.6	0.3	0	1.6	2.4	0.2	0.5	0.1	1.2	1.9	1.8	1	0.6	0.9	2.8	0.1	0.1	0.5	0.3	1.1	1.1	2.5	1.8	0.2	1.8	3.4	0.6	0.2	0.4	0	1	0	2.2	1	3.3	0	3.7	1.6	4	1.9	0.7	1.1	1.6	1.3	0.5	0.2	0.8	2.8	0.8	1.8	1.2	0.4	1	1.2	0.5	0.3	1.7	2	1.3	1.1	1.6	0.8	3.4	0.6	0.8	0.8	1.9	1	0.6	1.2	0.6	1	1.1	0.9	2.1	0.6	1.9	1.2	1.5	2.3	1.7	0.9	2.8	1.8	0.9											0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
